Roche HoldingsCH0012032048ROGROG
General
Growth
Dividend history
Status
Ex-date
Pay Date
Yield
% Change
Amount
Frequently asked questions
When does Roche Holdings pay dividends?
How often does Roche Holdings pay dividends?
What is the dividend yield of Roche Holdings?
When was Roche Holdings's last dividend payout date?
When do you have to have Roche Holdings in your portfolio to receive the last dividend?
How much was Roche Holdings's dividend in 2023?
How much was Roche Holdings's dividend in 2022?
What is Roche Holdings's next dividend?
Financials
Market Cap
$264.37B5Y beta
0.73EPS (TTM)
$15.72Free Float
719.09MP/E ratio (TTM)
20.58Revenue (TTM)
$69.88BEBITDA (TTM)
$26.58BFree Cashflow (TTM)
$3.94BPricing
Analyst Ratings
The price target is $323.28 and the stock is covered by 23 analysts.
Buy
9
Hold
9
Sell
5
Information
Roche Holding AG (Roche) is a research-based healthcare company. The Company's operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics. The Company develops medicines for various disease areas, including oncology, immunology, infectious diseases, ophthalmology and neuroscience. Its pharmaceutical products include Anaprox, Avastin, Bactrim, Bondronat, CellCept, Cotellic, Dilatrend, Dormicum, Invirase, Kadcyla, Kytril (Kevatril), Lariam, MabThera, Madopar, Neupogen, Pegasys, Perjeta, Pulmozyme, Rocaltrol, Rocephin and Roferon-A. The Company offers products for researchers, including cell analysis, gene expression, genome sequencing and nucleic acid purification.